|
Delayed
Japan Exchange
22:30:00 2026-09-08 EDT
|
5-day change | 1st Jan Change | ||
| 5,674.00 JPY | -1.49% |
|
-2.58% | +17.35% |
| 09-08 | Pharvaris' genetic disorder drug meets main goal in late-stage trial | RE |
| 09-04 | After obesity, pharma seeks its next mega-blockbuster in sleep |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 59.8B | |||||
| 1,024B | |||||
| 663B | - | - | - | ||
| 453B | |||||
| 349B | |||||
| 295B |
Select your edition
All financial news and data tailored to specific country editions
